Published in J Parasitol on June 01, 1989
Mass screening for Trypanosoma cruzi infections using the immunofluorescence, ELISA and haemagglutination tests on serum samples and on blood eluates from filter-paper. Bull World Health Organ (1990) 1.02
Development and comparison of enzyme immunoassays for diagnosis of Chagas' disease using fixed forms of Trypanosoma cruzi (Epimastigotes, Amastigotes, and Trypomastigotes) and assessment of antigen stability for the three assays. J Clin Microbiol (2004) 0.89
Design, construction, and evaluation of a specific chimeric antigen to diagnose chagasic infection. J Clin Microbiol (2006) 0.86
Development and Application of an ELISA Assay Using Excretion/Secretion Proteins from Epimastigote Forms of T. cruzi (ESEA Antigens) for the Diagnosis of Chagas Disease. J Trop Med (2012) 0.81
Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med (1999) 16.57
Cigarette smoking and colorectal cancer mortality in the cancer prevention study II. J Natl Cancer Inst (2000) 4.20
Estimation of population at risk of infection and number of cases of Leishmaniasis. Parasitol Today (1992) 3.24
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent. Trans R Soc Trop Med Hyg (2007) 2.53
Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. Cancer Res (1997) 2.22
Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan. Trop Med Int Health (2001) 2.08
Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults. Cancer Causes Control (1998) 2.04
Individual classification of mild cognitive impairment subtypes by support vector machine analysis of white matter DTI. AJNR Am J Neuroradiol (2012) 2.04
Integrating family medicine and pharmacy to advance primary care therapeutics. Clin Pharmacol Ther (2008) 2.04
Treatment of cutaneous leishmaniasis among travellers. J Antimicrob Chemother (2004) 2.01
Body mass index and colon cancer mortality in a large prospective study. Am J Epidemiol (2000) 1.91
New York City syndromic surveillance systems. MMWR Morb Mortal Wkly Rep (2004) 1.91
Increasing incidence of fluoroquinolone-resistant Mycobacterium tuberculosis in Mumbai, India. Int J Tuberc Lung Dis (2009) 1.76
Serodiagnosis of toxoplasma infection using a purified parasite protein (P30). Clin Exp Immunol (1985) 1.64
Involvement of FGF-8 in initiation, outgrowth and patterning of the vertebrate limb. Development (1996) 1.61
Direct coronary stenting versus stenting with balloon pre-dilation: immediate and follow-up results of a multicentre, prospective, randomized study. The DISCO trial. DIrect Stenting of COronary Arteries. Eur Heart J (2002) 1.61
Tumor necrosis factor expression in human epithelial tumor cell lines. J Clin Invest (1988) 1.53
Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline. Trans R Soc Trop Med Hyg (2004) 1.51
Domestic and peridomestic transmission of American cutaneous leishmaniasis: changing epidemiological patterns present new control opportunities. Mem Inst Oswaldo Cruz (2001) 1.50
Determinants of DNA yield and quality from buccal cell samples collected with mouthwash. Cancer Epidemiol Biomarkers Prev (2001) 1.49
Nasal continuous positive airway pressure in patients with COPD in acute respiratory failure. A study of the immediate effects. Chest (1993) 1.48
Towards a paradigm shift in the treatment of chronic Chagas disease. Antimicrob Agents Chemother (2013) 1.45
[Antigenic structure of helminthes. Immunological aspects of the host-parasite relationship]. Pathol Biol (1968) 1.45
Photodynamic therapy in the canine prostate using motexafin lutetium. Clin Cancer Res (2001) 1.43
Toxoplasma gondii: redistribution of monoclonal antibodies on tachyzoites during host cell invasion. Exp Parasitol (1985) 1.43
New geographical approaches to control of some parasitic zoonoses. Bull World Health Organ (1995) 1.41
Parasitic diseases and urban development. Bull World Health Organ (1990) 1.39
Fibronectin receptors on Trypanosoma cruzi trypomastigotes and their biological function. Nature (1984) 1.38
Dorsal cell fate specified by chick Lmx1 during vertebrate limb development. Nature (1995) 1.37
Apoptosis in a unicellular eukaryote (Trypanosoma cruzi): implications for the evolutionary origin and role of programmed cell death in the control of cell proliferation, differentiation and survival. Cell Death Differ (1995) 1.37
Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line. Proc Natl Acad Sci U S A (1987) 1.34
Isozyme evidence of lack of speciation between wild and domestic Triatoma infestans (Heteroptera: Reduviidae) in Bolivia. J Med Entomol (1987) 1.27
Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol (1998) 1.27
Stable behaviors associated with adults' 10-year change in body mass index and likelihood of gain at the waist. Am J Public Health (1997) 1.25
Epidemiological research at the American Cancer Society. Cancer Epidemiol Biomarkers Prev (2000) 1.23
Prospective evaluation and comparison of the direct agglutination test and an rK39-antigen-based dipstick test for the diagnosis of suspected kala-azar in Nepal. Trop Med Int Health (2003) 1.20
Major surface protein of Toxoplasma gondii (p30) contains an immunodominant region with repetitive epitopes. Eur J Immunol (1985) 1.20
Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal. Trop Med Int Health (2004) 1.20
Long-term expression of differentiated functions in hepatocytes cultured in three-dimensional collagen matrix. J Cell Physiol (1998) 1.20
The purine-cytosine permease gene of Saccharomyces cerevisiae: primary structure and deduced protein sequence of the FCY2 gene product. Mol Microbiol (1990) 1.19
Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors. Oncogene (1999) 1.19
Quantitative trait locus mapping for meat quality traits in an Iberian x Landrace F2 pig population. J Anim Sci (2002) 1.18
Nucleocytoplasmic shuttling of Smad1 conferred by its nuclear localization and nuclear export signals. J Biol Chem (2001) 1.18
Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis. Bull World Health Organ (1999) 1.16
Patterns of inpatient surgeries for the top four cancers in the United States, National Hospital Discharge Survey, 1988-95. Cancer Causes Control (2000) 1.16
Trypanosoma cruzi infection inhibited by peptides modeled from a fibronectin cell attachment domain. Science (1986) 1.15
Maternal and congenital syphilis in Bolivia, 1996: prevalence and risk factors. Bull World Health Organ (2003) 1.15
Lessons learned from the design and implementation of myocardial infarction adjudication tailored for HIV clinical cohorts. Am J Epidemiol (2014) 1.14
Multivitamin use and colon cancer mortality in the Cancer Prevention Study II cohort (United States). Cancer Causes Control (2001) 1.13
Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci (2003) 1.12
DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours. Br J Cancer (1996) 1.11
TrialDB: A web-based Clinical Study Data Management System. AMIA Annu Symp Proc (2003) 1.10
C-reactive protein serum level is a valuable and simple prognostic marker in non Hodgkin's lymphoma. Leuk Lymphoma (1998) 1.09
Tubal ligation and fatal ovarian cancer in a large prospective cohort study. Am J Epidemiol (1997) 1.08
Trypanosoma cruzi infection in B-cell-deficient rats. Infect Immun (1981) 1.08
Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells. Blood (1995) 1.06
The limb field mesoderm determines initial limb bud anteroposterior asymmetry and budding independent of sonic hedgehog or apical ectodermal gene expressions. Development (1996) 1.06
Treatment of Mediterranean visceral leishmaniasis. Bull World Health Organ (1995) 1.06
Phospholipase A2 activation and autoinduction of tumor necrosis factor gene expression by tumor necrosis factor. Cancer Res (1990) 1.06
Circulating immune complexes and anti-IgG antibodies in mucocutaneous leishmaniasis. Am J Trop Med Hyg (1980) 1.06
HIV viral load and response to antileishmanial chemotherapy in co-infected patients. AIDS (1999) 1.06
Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q. Br J Cancer (2006) 1.06
The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta. J Clin Invest (1995) 1.05
Cloning and sequencing of a 24-kDa Trypanosoma cruzi specific antigen released in association with membrane vesicles and defined by a monoclonal antibody. Biol Cell (1992) 1.05
The endogenous balance of soluble tumor necrosis factor receptors and tumor necrosis factor modulates cachexia and mortality in mice acutely infected with Trypanosoma cruzi. Infect Immun (1999) 1.05
Trypanosoma cruzi elongation factor 1-alpha: nuclear localization in parasites undergoing apoptosis. Gene (1996) 1.04
17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification. Oncogene (1999) 1.04
Influence of a family history of cancer within and across multiple sites on patterns of cancer mortality risk for women. Am J Epidemiol (1999) 1.03
Simultaneous mandibular and maxillary distraction in hemifacial microsomia in adults: avoiding occlusal disasters. Plast Reconstr Surg (1997) 1.03
Association between educational level and health related quality of life in Spanish adults. J Epidemiol Community Health (1999) 1.02
Application of the enzyme-linked immunoelectrotransfer blot to filter paper blood spots to estimate seroprevalence of cysticercosis in Bolivia. Am J Trop Med Hyg (1998) 1.02
Efficacy of ivermectin against Sarcoptes scabiei and Otodectes cynotis infestations of dogs. Vet Med Small Anim Clin (1981) 1.02
Melatonin regulation of antioxidant enzyme gene expression. Cell Mol Life Sci (2002) 1.02
Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy. Neurology (2004) 1.02
Truncated p110 ERBB2 induces mammary epithelial cell migration, invasion and orthotopic xenograft formation, and is associated with loss of phosphorylated STAT5. Oncogene (2012) 1.01
Zinc is essential for binding of p56(lck) to CD4 and CD8alpha. J Biol Chem (1998) 1.01
Interleukin-6 (IL-6) production in mice infected with Trypanosoma cruzi: effect of its paradoxical increase by anti-IL-6 monoclonal antibody treatment on infection and acute-phase and humoral immune responses. Infect Immun (1994) 1.01
Diethylstilbestrol and risk of fatal breast cancer in a prospective cohort of US women. Am J Epidemiol (1996) 1.01
[Comparative immunoelectrophoretic analysis of culture and bloodstream forms of "trypanosoma" (Trypanozoon) brucei gambiense". Demonstration of stage and antigenic type specific antigens (author's transl)]. Ann Immunol (Paris) (1975) 1.00
[Circulating immune complexes in human and experimental African trypanosomiasis]. Ann Soc Belg Med Trop (1977) 1.00
Family history score as a predictor of breast cancer mortality: prospective data from the Cancer Prevention Study II, United States, 1982-1991. Am J Epidemiol (1998) 0.99
Cerebral infarction after excessive use of nasal decongestants. J Neurol Neurosurg Psychiatry (1989) 0.99
Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression. J Infect Dis (1999) 0.98
Identification and isolation of Trypanosoma cruzi trypomastigote collagen-binding proteins: possible role in cell-parasite interaction. Parasitology (1988) 0.98
Detection of circulating antibodies in cutaneous leishmaniasis by enzyme-linked immunosorbent assay (ELISA). Am J Trop Med Hyg (1980) 0.97
Clinical characteristics of schizophrenia in multiply affected Spanish origin families from Costa Rica. Psychiatr Genet (2001) 0.97
Maternal Trypanosoma cruzi infection upregulates capacity of uninfected neonate cells To produce pro- and anti-inflammatory cytokines. Infect Immun (2000) 0.97
The cachexia associated with Trypanosoma cruzi acute infection in mice is attenuated by anti-TNF-alpha, but not by anti-IL-6 or anti-IFN-gamma antibodies. Parasite Immunol (1995) 0.96
Patient doses from fluoroscopically guided cardiac procedures in pediatrics. Phys Med Biol (2007) 0.96
Miliary tuberculosis and adult respiratory distress syndrome. Intensive Care Med (1987) 0.96
IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer. Oncogene (2012) 0.96
Trypanosoma cruzi cDNA encodes a tandemly repeated domain structure characteristic of small stress proteins and glutathione S-transferases. Biol Cell (1994) 0.96
Trypanosoma cruzi: immunity-induced in mice and rats by trypomastigote excretory-secretory antigens and identification of a peptide sequence containing a T cell epitope with protective activity. J Immunol (1993) 0.95
Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies. Br J Cancer (2006) 0.95
Prevalence and distribution of HHV-8 in different subpopulations, with and without HIV infection, in Spain. AIDS (2001) 0.95
Non-invasive testing of acquired long QT syndrome: evidence for multiple arrhythmogenic substrates. Cardiovasc Res (2001) 0.94